Arima Anastasios 4

What Happened

• Arima Anastasios, CEO of IPERIONX Ltd (IPX), was granted a package of equity awards on 2026-04-02 totaling 1,441,908 instruments. The filing shows three items: 237,944 shares (price N/A) and two derivative awards priced at A$18.00 (564,759 units, total A$10,165,662) and A$22.00 (639,205 units, total A$14,062,510). These are awards/grants (Form 4 transaction code A) rather than open-market purchases or sales.

Key Details

• Transaction date: 2026-04-02 (filing accession: 0001864247-26-000005).
• Awards granted: 237,944 (price N/A); 564,759 at A$18.00 (A$10,165,662); 639,205 at A$22.00 (A$14,062,510). Total instruments = 1,441,908.
• Shares owned after transaction: not specified in the provided excerpt.
• Notable footnotes from the filing:
  • F5: amounts/prices are in Australian dollars (A$).
  • F1/F3/F4: Ordinary shares trade on the ASX; American Depositary Shares (ADS) trade on Nasdaq; 1 ADS = 10 ordinary shares.
  • F6: Performance rights convert 1-for-1 into ordinary shares after meeting (a) four years of continuous service through 04/02/2030 and (b) an ASX 30-day VWAP of A$18.00.
  • F7: Options (where applicable) give the right to buy one ordinary share at the stated conversion/exercise price.
  • F2: Vesting schedule notes (in the filing) that 318,666 vest in Dec 2026 and 419,910 vest in Apr 2028.
• Filing timeliness: the report date and filing date are both 2026-04-02 (no late filing indicated in the provided data).

Context

• These are grant/award transactions (derivative awards and share grants), not open-market purchases or sales. Derivative awards (performance rights/options) typically convert to ordinary shares only after vesting and satisfaction of performance conditions (see F6/F7). Awards can be part of long-term incentive compensation and do not by themselves indicate immediate buying or selling in the market.